Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways
- 654 Downloads
The purpose was to examine the effect of pretreatment weight status on loco-regional progression for patients with squamous cell carcinoma of the head and neck (SCCHN) after receiving definitive concurrent chemoradiation therapy (CCRT).
In an expanded cohort of 140 patients, we retrospectively reviewed weight status and loco-regional progression of SCCHN patients treated with CCRT between 2004 and 2010.
Pretreatment ideal body weight percentage (IBW%) was statistically significantly different for patients with disease progression than for those without progression (p = 0.02) but was not an independent predictor of progression. Median pretreatment IBW% was 118 (72–193) for the progression-free group and was 101.5 (73–163) for the group with progression. Both groups suffered clinically severe weight loss of approximately 9 % from baseline to end treatment.
Pretreatment weight status, a very crude indicator of nutrition status, may have prognostic value in patients with SCCHN undergoing definitive CCRT. Inadequate nutritional status in these patients has been associated with poor clinical outcomes and decreased quality of life. Based on this report and others, the best next steps include routine validated malnutrition screening and the testing of evidence-based nutrition care protocols with the goals of minimizing weight loss and improvement of quality of life.
KeywordsHead and neck cancer Nutrition Nutrition status Radiation therapy Weight loss Quality of life
This work was funded in part by the National Institutes of Health grant number R25CA114101.
Conflict of interest
- 1.American Cancer Society (2012) Cancer facts & figures 2012. American Cancer Society, AtlantaGoogle Scholar
- 2.Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA (2006) Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 24(7):1064–1071. doi: 10.1200/JCO.2005.01.5867 CrossRefPubMedGoogle Scholar
- 3.de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY (2006) Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan–Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64(2):363–373. doi: 10.1016/j.ijrobp.2005.03.006 CrossRefPubMedGoogle Scholar
- 5.Rades D, Stoehr M, Kazic N, Hakim SG, Walz A, Schild SE, Dunst J (2008) Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys 70(4):1108–1114. doi: 10.1016/j.ijrobp.2007.07.2380 CrossRefPubMedGoogle Scholar
- 6.Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK (2010) Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. doi: 10.1002/hed.21640 PubMedGoogle Scholar
- 7.McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Sullivan M, Mashtare TL Jr, Khan MK, Loree TR, Singh AK (2009) Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol. doi: 10.1097/COC.0b013e3181967dd0 PubMedGoogle Scholar
- 9.Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, Pavese I, Satta F, Tosti M, Palladino A, Coiro G, Di Palma M (2008) Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30(4):503–508. doi: 10.1002/hed.20737 CrossRefPubMedGoogle Scholar
- 10.Hamwi GJ (1964) Therapy: changing dietary needs. In: Danowski TS (ed) Diabetes mellitus: diagnosis and treatment, 1st edn. American Diabetes Association, New York, pp 73–78Google Scholar
- 11.Meyenfeldt M (2005) Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs 9(S35–8)Google Scholar
- 12.Campillo B, Paillaud E, Uzan I, Merlier I, Abdellaoui M, Perennec J, Louarn F, Bories PN (2004) Value of body mass index in the detection of severe malnutrition: influence of the pathology and changes in anthropometric parameters. Clin Nutr 23(4):551–559. doi: 10.1016/j.clnu.2003.10.003 CrossRefPubMedGoogle Scholar
- 13.Rutter C, Yovino S, Taylor R, Wolf J, Cullen K, Ord R, Athas M, Zimrin A, Strome S, Suntharalingam M (2011) Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy. Head Neck 33(10):1441–1447CrossRefPubMedGoogle Scholar
- 15.Silver H, Dietrich M, Murphy B (2007) Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 29(10):893–900CrossRefPubMedGoogle Scholar
- 16.Clavel S, Fortin B, Desprs P, Donath D, Soulires D, Khaouam N, Charpentier D, Blair M, Guertin L, Nguyen Tan P (2011) Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach. Int J Rad Oncol, Biol, Phys 79(3):763–769CrossRefGoogle Scholar
- 17.Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD (2005) Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) 19(3):371–379, discussion 380–372, 387Google Scholar
- 20.Hammerlid E, Silander E, Hornestam L, Sullivan M (2001) Health-related quality of life three years after diagnosis of head and neck cancer—a longitudinal study. Head Neck 23(2):113–125. doi: 10.1002/1097-0347(200102)23:2<113::AID-HED1006>3.0.CO;2-W CrossRefPubMedGoogle Scholar
- 21.Garcia-Peris P, Paron L, Velasco C, de la Cuerda C, Camblor M, Breton I, Herencia H, Verdaguer J, Navarro C, Clave P (2007) Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: impact on quality of life. Clin Nutr 26(6):710–717. doi: 10.1016/j.clnu.2007.08.006 CrossRefPubMedGoogle Scholar
- 24.Shronts EP, Fish JA, Pesce-Hammond K (1998) Assessment of nutritional status. In: The ASPEN Nutrition Support Practice Manual. ASPEN, Silver Spring, MDGoogle Scholar
- 26.Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, Twomey P (1997) Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 66(3):683–706PubMedGoogle Scholar
- 28.Neelemaat F, Kruizenga HM, de Vet HC, Seidell JC, Butterman M, van Bokhorst-de van der Schueren MA (2008) Screening malnutrition in hospital outpatients. Can the SNAQ malnutrition screening tool also be applied to this population? Clin Nutr 27(3):439–446. doi: 10.1016/j.clnu.2008.02.002 CrossRefPubMedGoogle Scholar
- 30.Platek ME, McCloskey SA, Cruz M, Burke MS, Reid ME, Wilding GE, Rigual NR, Popat SR, Loree TR, Gupta V, Warren GW, Sullivan M, Hicks WL Jr, Singh AK (2012) Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Head Neck. doi: 10.1002/hed.23024 PubMedGoogle Scholar
- 32.Fogt EJ, Bell SJ, Blackburn GL (1995) Nutrition assessment of the elderly. In: Morley JE, Glick Z, Rubenstein LZ (eds) Geriatric nutrition, 2nd edn. Raven, New YorkGoogle Scholar
- 34.Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L (2008) Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiotherapy Oncol 87(2):253–259. doi: 10.1016/j.radonc.2008.03.010 CrossRefGoogle Scholar
- 36.Atasoy B, Yonal O, Demirel B, Dane F, Yilmaz Y, Kalayci C, Abacioglu U, Imeryuz N (2012) The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol 269(1):275–282CrossRefPubMedGoogle Scholar
- 38.Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35. doi: 10.1056/NEJMoa0912217 CrossRefPubMedGoogle Scholar
- 39.Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J National Cancer Inst 100(4):261–269. doi: 10.1093/jnci/djn011 CrossRefGoogle Scholar